Computerized Thermal Imaging, Inc. (OTC Bulletin Board: COIB) today announced recent sales and lease agreements for placement of CTI medical equipment.

Tampa Bay Orthopedic Specialists (TBOS) of Tampa, FL has contracted with CTI for installation and use of a CTI imaging suite consisting of one Thermal Imaging Processor (TIP) and two Photonic Stimulators (PS). TBOS is one of the largest orthopedic groups in central Florida and is a leading orthopedic surgical and physical therapy facility, specializing in surgical treatment of hand, upper extremity, foot and ankle, and repetitive use injuries. TBOS intends to leverage CTI's FDA-approved imaging suite by introducing physiological screening and treatment modalities in both their surgical and physical therapy units. Dr. Richard Herrick of TBOS, a world-renowned hand surgeon, has been instrumental in introducing CTI products into the clinic. Installation and training for physicians and staff is scheduled to commence prior to March 15, 2006.

CTI also announced a contract to sell one imaging suite consisting of one Thermal Imaging Processor (TIP) and two Photonic Stimulators (PS) to the Covina Wellness Center (CWC) in West Covina, CA. The CWC is a new facility specializing in physical therapy and women's health. CTI TIP screening for breast cancer will be one of the new services offered in the clinic. Installation and training for physicians and staff by CTI is scheduled to commence prior to the end of March 2006. The clinic plans to open for patients in early April of 2006.

R.V. Secord, CEO of CTI, commented on the developments, "As forecast, CTI began execution of its redirection efforts at the start of 2006 and is focused on strengthening new sales and aftermarket support pipelines. This is possible because the CTI infrared system continues to perform favorably relative to other commercially available IR systems."

About Computerized Thermal Imaging, Inc. (TM)

Computerized Thermal Imaging Inc. is in business to improve the quality of life through the development and deployment of thermal INFRARED imaging and associated technologies. While CTI's infrared technology offers multiple existing and potential applications, its primary focus is in medical and industrial applications. CTI markets two FDA cleared pain management products -- the Thermal Imaging Processor (TIP) and an infrared light therapy device called the Photonic Stimulator.

For more information please contact Pam Bloedel at pbloedel@cti-net.com or sales@cti-net.com. Additionally CTI can be reached at 801-776-4700.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Among those risks, trends and uncertainties are CTI's pending application before the FDA seeking pre-market approval of CTI's BCS 2100 breast imaging system, CTI's ability to raise additional capital to fund cash requirements for future operations and CTI's ability to continue as a going concern. In particular, careful consideration should be given to cautionary statements made in the various reports CTI has filed with the Securities and Exchange Commission. CTI undertakes no duty to update or revise these forward-looking statements.

Source: prnewswire